Home About Us Pipeline Expanded Access Investors & Media Contact Us BPDCN x Stemline Therapeutics is now part of Menarini Group Read more CLINICAL TRIALS We are focused on the development of a broad pipeline of innovative, transformative therapies for oncology patients. View All INVESTORS & MEDIA Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer. Read More VISIT BPDCNINFO.COM A resource for patienys with blastic plasmacytoid dendritic cell neoplasm. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive and deadly blood cancer that often presents with skin lesions. Read more THE MENARINI GROUP The Menarini Group is present in 140 countries worldwide, a guarantee of internationally recognised quality. The achieved results are proof of an efficient strategy based on Research, Innovation and Internationalisation, along with the ability to recognize and meet the needs of physicians and patients alike. Read more About Us Management Business Development Pipeline Clinical Trials Scientific Presentations Investors & Media News & Events Contact Us BPDCN © 2021 – Stemline Therapeutics, Inc. All rights reserved | Privacy & Terms of Use | CCPA Policy | Cookie Policy Stemline Therapeutics is a society of the Menarini Group